T2 Biosystems Inc (FRA:3T2)
€ 4.06 -0.15 (-3.56%) Market Cap: 67.24 Mil Enterprise Value: 106.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q2 2019 T2 Biosystems Inc Earnings Call Transcript

Jul 30, 2019 / 08:30PM GMT
Release Date Price: €130.36 (-4.18%)
Operator

Greetings and welcome to the T2 Biosystems 2019 Second Quarter Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to our host, Matt Clawson of W2O Group.

Matthew Clawson
W2O Group - Practice Lead of IR

Thank you, Diego, and good afternoon, everyone. Thanks for joining us for the T2 Biosystems Second Quarter 2019 Financial Results Conference Call. On the call to discuss the results and operational highlights of the quarter ended June 30, 2019, are President and CEO, John McDonough; and Chief Financial Officer, John Sprague. We are also joined today by Tom Lowery, Chief Scientific Officer; Sandy Estrada, Vice President of Medical Affairs. The executive team will open the call with some prepared remarks, followed by a question-and-answer period.

I'd like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot